One-third of pediatric gastroenterologists are experiencing professional burnout, according to the results of a new survey published by authors from the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) task force investigating burnout in the field. The 35-item survey was sent to 1,791 NASPGHAN members, 408 (22.7%) of whom returned the survey. A total of 28.8% reported being at high risk for emotional exhaustion, 17.5% reported high risk for depersonalization, and 33% reported overall burnout. Younger pediatric gastroenterologists appeared to be at particular risk for burnout, with survey respondents who were 44 years of age or younger reporting…
Author: Rutali Thakur
Rapid blood test sensitive to advanced adenomas could improve patient prognosis and ultimately reduce mortality ORLANDO, Fla.–(BUSINESS WIRE)– Dxcover Limited, a clinical-stage diagnostics company developing spectroscopic liquid biopsy technology for early detection of multiple cancers, today presented new data in a presentation titled “Early Detection and Molecular Markers of Prevention” on the detection of colorectal cancer (CRC) using the company’s liquid biopsy platform at the 2023 American Association for Cancer Research (AACR) Annual Meeting in Orlando, Florida from April 14-19. Co-founder and CTO Matthew Baker, PhD, outlined data from a preclinical study evaluating the Dxcover® Cancer Liquid Biopsy platform’s capabilities to…
Meridian Bioscience has announced FDA 510(k) clearance of its Curian Shiga Toxin assay intended for detection and differentiation of Shiga toxin 1 and 2 within a single device, according to a company release. By adding Shiga toxin detection, the company has expanded the platform’s foodborne immunofluorescent testing capabilities beyond Campylobacter.
Irritable bowel syndrome impacts between 25 and 45 million people in the U.S., causing symptoms including severe abdominal pain and altered bowel habits. A number of famous athletes, musicians and sports stars deal with the disease every day. Ten celebrities with IBS: Sports Franklin Gutierrez. Former Seattle Mariners center fielder Franklin Gutierrez was diagnosed with IBS in 2011 after experiencing severe stomach pain. Music Cam’ron. In 2006, rapper Cam’ron released “I.B.S.,” a song detailing his experience with IBS. Cher. Singer Cher has had IBS for years and has managed symptoms by altering her diet and practicing yoga.
Abstract To meet the needs of the colorectal cancer (CRC) patient population, colorectal cancer screening is continuously updated. The most significant advice is to start CRC screening exams at age 45 for people at average risk for CRC. CRC testing is divided into two categories: stool-based tests and visual inspections. High-sensitivity guaiac-based fecal occult blood testing, fecal immunochemical testing, and multitarget stool DNA testing are stool-based assays. Colon capsule endoscopy and flexible sigmoidoscopy are visualization examinations. There have been arguments about the importance of these tests in detecting and managing precursor lesions because of the lack of validation of screening…
The American College of Gastroenterology recently released a new clinical guideline on the diagnosis and management of subepithelial lesions of the gastrointestinal tract (Am J Gastroenterol 2023;118[1]:46-58). GEN’s Sarah Tilyou spoke with lead author Brian C. Jacobson, MD, MPH, FACG, AGAF, FASGE, a gastroenterologist at Massachusetts General Hospital and an associate professor of medicine at Harvard Medical School, in Boston, about the impetus for the guideline and what it means to GI practice. GEN: What prompted the guideline? Dr. Jacobson: This was a guideline about a topic that had been addressed by other organizations, such as the American Society for Gastrointestinal Endoscopy…
PALO ALTO, Calif.–(BUSINESS WIRE)–Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, announced today that Palmetto GBA, a Medicare administrative contractor for the Molecular Diagnostics Services program (MolDX), has conveyed coverage for the Guardant360 Response test. Guardant360 Response is the first blood-only test that enables doctors to track molecular response through changes in circulating tumor DNA (ctDNA) levels, to get an early indication of metastatic or advanced cancer patient response to immune checkpoint inhibitor therapy. Following this decision, the Guardant360 Response test is now covered for fee-for-service Medicare patients in the U.S. with metastatic or inoperable solid tumors who…
The double whammy of pandemic burnout and the aging of baby boomer physicians has, indeed, the makings of some scary headlines. A recent survey by Elsevier Health predicts that up to 75% of healthcare workers will leave the profession by 2025. And a 2020 study conducted by the Association of American Medical Colleges (AAMC) projected a shortfall of up to 139,000 physicians by 2033. “We’ve paid a lot of attention to physician retirement,” says Michael Dill, AAMC’s director of workforce studies. “It’s a significant concern in terms of whether we have an adequate supply of physicians in the US to meet our nation’s medical…
Gaslighting occurs in a relationship when one person is made to feel manipulated and questions their reality. Medical gaslighting takes place when a patient’s concerns about their health are dismissed, minimized or they do not feel heard. The invitation to write an editorial about gaslighting in gastroenterology comes at an interesting time when resources in medical settings are extremely limited, affecting both patients and providers.
AGA released a new Clinical Practice Update providing commentary to help navigate and incorporate telemedicine into your gastroenterology practice. Telemedicine has been a valued component of some gastroenterology practices for years. However, the use of telemedicine increased abruptly in mid-2020, as individual and population-wide safety concerns during the COVID-19 pandemic accelerated demand from both patient and provider communities, and third-party payers removed barriers to reimbursement. Although telemedicine visits have fallen and in-person visits have increased gradually since the initial wave of COVID-19 in 2020, telemedicine remains an important format for ambulatory care, and is likely to persist long after the current pandemic…